Thus, our findings indicate that CRP concentration evaluation in routine clinical practice may have an advantage as a prognostic biomarker in CRC patients, as this protein most comprehensively reflects the clinicopathological features of the tumor. This evidence concerns the gene CRP and colorectal carcinoma.